by Jerome Puginier | Dec 12, 2022 | News
Controversies seem to be waning with new scientific data being publish on a regular basis. In a very recent paper*, Carolina Grana Possamai et al. conclude, after having analyzed 41 randomized clinicaltrials assessing 12 different vaccines, that:...
by Jerome Puginier | Nov 24, 2022 | News
The following example is in contrast enhanced ultrasound ; ceus ; as reported by Qin-Xian Zhao et al.* who developed a DL model based on quantitative analysis of contrast-enhanced ultrasound (CEUS) images that predicts early recurrence...
by Jerome Puginier | Nov 22, 2022 | News
Do you have your own idea? If you need elements of answer, we suggest reading the very exhaustive review by Musga Qureischi , Julia Mohr , Estibaliz Arellano , Sarah Elspeth Knudsen , Farrukh Vohidovn and Andoni...
by Jerome Puginier | Nov 18, 2022 | News
Transcriptomics, beyond genomics and beneath proteomics provide us with precious information on geneexpression and have promising clinical applications. In their recent paper Kelley Nunez et al. from Ochsner Health in New Orleans present one of them that, through a...
by Jerome Puginier | Oct 25, 2022 | News
A yes answer would not be fair… a no answer would not be true… so what? Well, think about what’s happening in your business… progress relates to the ability to diagnose and treat more and more conditions through more and more pathways and in a...
by Jerome Puginier | Oct 20, 2022 | News
An update and indications on future directions are available in the very interesting paper* from Antea DeMarsilis just published in Metabolism It presents each class of agents by: ✔️mechanism of action✔️details of administration ✔️side effect profile✔️...
Recent Comments